Jiangsu Hengrui | 600276 - Sales Revenues

Stock Price
57.50
Daily Change
-0.66 -1.13%
Monthly
-9.95%
Yearly
26.96%
Q1 Forecast
56.88

Jiangsu Hengrui reported CNY7.43B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Sh Fosun Pharma CNY 9.88B 125.79M Sep/2025
Sh Pharmaceutical CNY 73.48B 2.65B Sep/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
Wuxi Apptec CNY 11.53B 390M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025